Validity and reliability of the Indonesian version of the 9-item Inflammatory Bowel Disease Questionnaire (IBDQ-9)

Authors

  • Dekta Filantropi Esa Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Hamzah Shatri Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Cleopas Martin Rumende Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Adityo Susilo Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Hasan Maulahela Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Achmad Fauzi Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Marcellus Simadibrata Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia

DOI:

https://doi.org/10.13181/mji.oa.236848

Keywords:

inflammatory bowel disease, quality of life

Abstract

BACKGROUND Decreasing the quality of life (QoL) of patients with inflammatory bowel disease (IBD) will increase morbidity and mortality. A valid and reliable instrument is needed to assess the QoL of patients with IBD. This study aimed to analyze the validity and reliability of the Indonesian version of the 9-item Inflammatory Bowel Disease Questionnaire (IBDQ-9).

METHODS This cross-sectional study was conducted using the Indonesian version of the IBDQ-9 in adult patients with IBD at the Gastroenterology Outpatient Clinic, Cipto Mangunkusumo Hospital, Jakarta, in November 2022. Patients aged 18 to 59 years who had experienced IBD for at least 2 weeks and provided informed consents were included. The total score of the IBDQ-9 Indonesian version was compared with the 36-item Short-Form Health Survey (SF-36) using the Spearman's correlation test. Reliability tests were examined using Cronbach’s alpha and the intraclass correlation coefficient (ICC).

RESULTS A total of 124 participants were included in this study. The Spearman's test showed a high and significant result for the IBDQ-9 Indonesian version and the SF-36 (r = 0.769 and p<0.001). Cronbach’s alpha and ICC coefficient were equal to 0.883.

CONCLUSIONS This study provided evidence of the good validity and reliability of the IBDQ-9 Indonesian version for assessing the QoL of patients with IBD in Indonesia.

Downloads

Download data is not yet available.

References

Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361(21):2066-78. https://doi.org/10.1056/NEJMra0804647

Vegh Z, Kurti Z, Lakatos PL. Epidemiology of inflammatory bowel diseases from west to east. J Dig Dis. 2017;18(2):92-8. https://doi.org/10.1111/1751-2980.12449

Makmun D, Renaldi K, Maulahela H, Utari AP, Pribadi RR, Muzellina VN, et al. [National consensus on management of inflammatory bowel disease (IBD) in Indonesia (revised 2019)]. Makmun D, Fauzi A, Maulahela A, Pribadi RR, editors. Jakarta: Interna Publishing; 2019. p. 1-52. Indonesian.

Huppertz-Hauss G, Høivik ML, Langholz E, Odes S, Småstuen M, Stockbrugger R, et al. Health-related quality of life in inflammatory bowel disease in a European-wide population-based cohort 10 years after diagnosis. Inflamm Bowel Dis. 2015;21(2):337-44. https://doi.org/10.1097/MIB.0000000000000272

Alcalá MJ, Casellas F, Fontanet G, Prieto L, Malagelada JR. Shortened questionnaire on quality of life for inflammatory bowel disease. Inflamm Bowel Dis. 2004;10(4):383-91. https://doi.org/10.1097/00054725-200407000-00009

Gholamrezaei A, Haghdani S, Shemshaki H, Tavakoli H, Emami MH. Linguistic validation of the inflammatory bowel disease questionnaire-short form (IBDQ-9) in Iranian population. J Isfahan Med Sch. 2011;28(123):1850-9.

Duricova D, Burisch J, Jess T, Gower-Rousseau C, Lakatos PL; ECCO-EpiCom. Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature. J Crohns Colitis. 2014;8(11):1351-61. https://doi.org/10.1016/j.crohns.2014.05.006

Ouchi Y, Rakugi H, Arai H, Akishita M, Ito H, Toba K, et al. Redefining the elderly as aged 75 years and older: proposal from the Joint Committee of Japan Gerontological Society and the Japan Geriatrics Society. Geriatr Gerontol Int. 2017;17(7):1045-7. https://doi.org/10.1111/ggi.13118

United Nations Department of Economic and Social Affairs, Population Division. World population prospects 2022: summary of results. United Nations: New York; 2022. p. 1-9. UN DESA/POP/TR/NO.3.

Ng SC, Kaplan GG, Tang W, Banerjee R, Adigopula B, Underwood FE, et al. Population density and risk of inflammatory bowel disease: a prospective population-based study in 13 countries or regions in Asia-Pacific. Am J Gastroenterol. 2019;114(1):107-15. https://doi.org/10.1038/s41395-018-0233-2

Ng SC, Zeng Z, Niewiadomski O, Tang W, Bell S, Kamm MA, et al. Early course of inflammatory bowel disease in a population-based inception cohort study from 8 countries in Asia and Australia. Gastroenterology. 2016;150(1):86-95.e3; quiz e13-4. https://doi.org/10.1053/j.gastro.2015.11.019

Keller R, Mazurak N, Fantasia L, Fusco S, Malek NP, Wehkamp J, et al. Quality of life in inflammatory bowel diseases: it is not all about the bowel. Intest Res. 2021;19(1):45-52. https://doi.org/10.5217/ir.2019.00135

M'Koma AE. The multifactorial Etiopathogeneses interplay of inflammatory bowel disease: an overview. Gastrointest Disord (Basel). 2019;1(1):75-105. https://doi.org/10.3390/gidisord1010007

Villoria A, García V, Dosal A, Moreno L, Montserrat A, Figuerola A, et al. Fatigue in out-patients with inflammatory bowel disease: prevalence and predictive factors. PLoS One. 2017;12(7):e0181435. https://doi.org/10.1371/journal.pone.0181435

Magharei M, Jaafari S, Mansouri P, Safarpour A, Taghavi SA. Effects of self-management education on self-efficacy and quality of life in patients with ulcerative colitis: a randomized controlled clinical trial. Int J Community Based Nurs Midwifery. 2019;7(1):32-42.

Neubauer K, Arlukiewicz A, Paradowski L. Quality of life in inflammatory bowel disease. Adv Clin Exp Med. 2009;18(1):79-83.

Kobayashi T, Siegmund B, Le Berre C, Wei SC, Ferrante M, Shen B, et al. Ulcerative colitis. Nat Rev Dis Primers. 2020;6(1):74. https://doi.org/10.1038/s41572-020-0205-x

Yarlas A, Bayliss M, Cappelleri JC, Maher S, Bushmakin AG, Chen LA, et al. Psychometric validation of the SF-36® Health Survey in ulcerative colitis: results from a systematic literature review. Qual Life Res. 2018;27(2):273-90. https://doi.org/10.1007/s11136-017-1690-6

Chen XL, Zhong LH, Wen Y, Liu TW, Li XY, Hou ZK, et al. Inflammatory bowel disease-specific health-related quality of life instruments: a systematic review of measurement properties. Health Qual Life Outcomes. 2017;15(1):177. https://doi.org/10.1186/s12955-017-0753-2

Knowles SR, Graff LA, Wilding H, Hewitt C, Keefer L, Mikocka-Walus A. Quality of life in inflammatory bowel disease: a systematic review and meta-analyses-part I. Inflamm Bowel Dis. 2018;24(4):742-51. https://doi.org/10.1093/ibd/izx100

López-Vico M, Sánchez-Capilla AD, Redondo-Cerezo E. Quality of life in cohabitants of patients suffering inflammatory bowel disease: a cross-sectional study. Int J Environ Res Public Health. 2021;19(1):115. https://doi.org/10.3390/ijerph19010115

Published

2023-12-22

How to Cite

1.
Esa DF, Shatri H, Rumende CM, Susilo A, Maulahela H, Fauzi A, Simadibrata M. Validity and reliability of the Indonesian version of the 9-item Inflammatory Bowel Disease Questionnaire (IBDQ-9). Med J Indones [Internet]. 2023Dec.22 [cited 2024Dec.6];32(3):168-72. Available from: http://mji.ui.ac.id/journal/index.php/mji/article/view/6848

Issue

Section

Clinical Research
Abstract viewed = 296 times

Most read articles by the same author(s)